gw9662 has been researched along with Nephritis* in 1 studies
1 other study(ies) available for gw9662 and Nephritis
Article | Year |
---|---|
PPARγ activation by baicalin suppresses NF-κB-mediated inflammation in aged rat kidney.
Baicalin, a herb-derived flavonoid compound, has beneficial activities, including the modulation of oxidative stress and inflammation. Nuclear receptor peroxisome proliferator-activated receptor-γ (PPARγ) is a ligand-activated transcription factor that plays an important role in regulating nuclear factor-κB (NF-κB)-induced age-related inflammation. We investigated the anti-inflammatory action of baicalin, which depends on its ability to activate PPARγ, and subsequently to suppress NF-κB. We examined baicalin-treated kidney tissue from 24-month-old Fischer 344 aged rats (10 or 20 mg/kg/day for 10 days) and baicalin-fed mice (10 mg/kg/day for 3 days) for in vivo investigations, and used endothelial YPEN-1 cells for in vitro studies. In the baicalin-fed aged rats, there was a marked enhancement of both nuclear protein levels and DNA binding activity of PPARγ, and a decreased expression of NF-κB target genes (VCAM-1, IL-1β, and IL-6) compared with non-baicalin-fed aged rats. Furthermore, to confirm the anti-inflammatory action of PPARγ activated by baicalin, we used lipopolysaccharide (LPS)-treated cells and mice. The results showed that baicalin induced PPARγ-selective activation in YPEN-1 cells, and that the effects of baicalin were blocked by the PPARγ receptor antagonist, GW9662. In addition, baicalin treatment prevented RS generation, NF-κB activation and the expression of pro-inflammatory genes, whereas it increased PPARγ expression in LPS-treated cells and mouse kidney. Our data suggest that baicalin-induced PPARγ expression reduced age-related inflammation through blocking pro-inflammatory NF-κB activation. These results indicate that baicalin is a novel PPARγ activator and that this agent may have the potential to minimize inflammation. Topics: Age Factors; Aging; Anilides; Animals; Anti-Inflammatory Agents; Antioxidants; Cell Line; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelial Cells; Flavonoids; Inflammation Mediators; Kidney; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Nephritis; NF-kappa B; PPAR gamma; Rats; Rats, Inbred F344; Transfection; Up-Regulation | 2012 |